Pegloticase

How is Pegloticase dosed?

The dosage of pegloticase is determined based on the patient's weight and medical condition. The typical adult dose is 8 mg, administered as an intravenous infusion over a 2-hour period, every 2 weeks. It is important to follow the doctor's instructions regarding dosage and frequency. Please consult your healthcare provider for personalized dosing information and potential adjustments based on your specific condition.

What is the dosage form of Pegloticase?

Pegloticase is available in the form of a solution for intravenous administration.

How is Pegloticase administered?

Pegloticase is administered by a healthcare professional through a needle inserted into a vein in the arm. The medication is slowly injected into the vein over a period of approximately 2 hours. The dose and frequency of administration depend on the patient's condition and treatment plan.

What are common precautions when taking Pegloticase?

Common precautions when taking pegloticase include:

  1. Allergies: Inform your doctor about any unusual or allergic reactions to this medication or other drugs. Also, disclose any other allergies you may have, such as to foods, dyes, preservatives, or animals.
  2. Pediatric Use: The safety and effectiveness of pegloticase have not been established in children.
  3. Geriatric Use: Consult your doctor before using this medication if you are an elderly patient, as specific geriatric-related concerns have not been identified.
  4. Breastfeeding: Limited information is available on the safety of using pegloticase while breastfeeding. Consult your doctor before taking this medication if you are breastfeeding.
  5. Drug Interactions: Inform your doctor about all the medications you are taking, as interactions may occur.